Fig. 6From: An international comparative analysis of public reimbursement of orphan drugs in Canadian provinces compared to European countriesProportion of orphan drugs with public reimbursement in European countries with EMA approval compared to provinces with Health Canada approval. EMA, European Medicine Agency; HC, Health Canada; PEI, Prince Edward IslandBack to article page